Bigbear Pharmaceutical·Medication Guide

• Purchase Channels for Axitinib

  Axitinib is a targeted therapeutic agent for renal cell carcinoma, which has been increasingly widely used in clinical practice in recent years. Devel···【Read More】

  Update: 2026-03-18Source: Haiou HealthViews: 166

• ​Precautions for Enxidipine

  Precautions for EnxidipineEnxidipine is used for relapsed or refractory acute myeloid leukemia (AML) with an IDH2 mutation. An FDA-approved diagnostic···【Read More】

  Update: 2026-03-18Source: Haiou HealthViews: 146

• Precautions for Apellixis Use

  Apellixis is a targeted therapy for a specific type of breast cancer, developed by Novartis in Switzerland and approved by the US FDA in 2019.Precauti···【Read More】

  Update: 2026-03-18Source: Haiou HealthViews: 127

• What to Do in Case of Overdose with Avatrombopag Ethanolamine Tablets

  The maximum recommended daily dose of this drug is 75 mg. Taking more than 75 mg per day, or exceeding the daily dose recommended by a physician based···【Read More】

  Update: 2026-03-18Source: Haiou HealthViews: 147

• What to Do If a Dose of Avatrombopag Ethanolamine Tablets Is Missed

  If one dose is missed during treatment, continue with the original drug dosage and administration schedule.Do not take a double dose at one time to av···【Read More】

  Update: 2026-03-18Source: Haiou HealthViews: 141

• How Long Does the Efficacy of Avatrombopag Ethanolamine Tablets Typically Last

  The elimination half-life of this product is 21–32 hours, meaning it takes 21–32 hours for the plasma drug concentration or total body drug level to d···【Read More】

  Update: 2026-03-18Source: Haiou HealthViews: 143

• How Long Does It Take for Avatrombopag Ethanolamine Tablets to Take Effect

  After oral administration, the drug reaches peak plasma concentration in patients within 2–6 hours. Platelet counts begin to increase within 1–2 weeks···【Read More】

  Update: 2026-03-18Source: Haiou HealthViews: 133

• How Long Does the Efficacy of Lenalidomide Typically Last

  According to research data:In healthy volunteers taking standard doses, the half-life of the drug (time required for the concentration in the body to ···【Read More】

  Update: 2026-03-18Source: Haiou HealthViews: 130

• What should be done if an overdose of lenalidomide occurs

  Currently, there is no established treatment plan for an overdose of this medication. According to early studies: When healthy individuals took a sing···【Read More】

  Update: 2026-03-18Source: Haiou HealthViews: 142

• What should be done if a dose of lenalidomide is missed

  The medication should be taken at a fixed time every day. If the forgotten time is less than 12 hours, you can take the missed dose immediately. If th···【Read More】

  Update: 2026-03-18Source: Haiou HealthViews: 132

• How long does it generally take for lenalidomide to start working

  In healthy individuals taking the drug on an empty stomach, it is rapidly absorbed, typically reaching peak concentration in the blood between half an···【Read More】

  Update: 2026-03-18Source: Haiou HealthViews: 137

• FDA Approves Ninlaro (ixazomib) for Multiple Myeloma

  Approval AnnouncementNovember 20, 2015 -- Today the U.S. Food and Drug Administration granted approval for Ninlaro (ixazomib) in combination with two ···【Read More】

  Update: 2026-03-18Source: Haiou HealthViews: 178

• First-Line Maintenance Therapy with Ixazomib, a Novel Multiple Myeloma Drug, Significantly Prolongs

  Study Overview and Release ContextTakeda Pharmaceutical Company Limited, a Japanese pharmaceutical enterprise, recently announced the results of two c···【Read More】

  Update: 2026-03-18Source: Haiou HealthViews: 178

• Novel Triple Combination Regimen for MM: Empliciti + Pomalidomide + Dexamethasone

  Overview of Empliciti Triple TherapyEmpliciti is a multiple myeloma therapy developed by Bristol-Myers Squibb (BMS). The U.S. regulatory authorities h···【Read More】

  Update: 2026-03-18Source: Haiou HealthViews: 147

• Empliciti Triple Combination Therapy Receives CHMP Positive Opinion Following FDA Approval

  Approval OverviewRecently, the Committee for Medicinal Products for Human Use (CHMP) of the European Union has granted a positive opinion for the trip···【Read More】

  Update: 2026-03-18Source: Haiou HealthViews: 150